The arrival of the No Surprises Act led to the unraveling of Envision’s “secret sauce” business model, according to a prominent healthcare economist, and ultimately
Both gabapentinoid and opioid prescribing rose among post-surgical older adults, serial cross-sectional data showed. Across nearly 500,000 Medicare recipients, the rate of new postoperative gabapentinoid
CHICAGO — The traditional body mass index (BMI) measure may have misclassified millions of Americans as not having obesity, according to National Health and Nutrition
The American Medical Association (AMA) House of Delegates (HOD) meeting in Chicago this past week featured discussions on a wide variety of issues, from Medicare
The FDA has granted accelerated approval to glofitamab (Columvi) for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), Genentech, the drug’s developer, announced
In a single-center case series to evaluate the efficacy and safety of high-dose upadacitinib (Rinvoq) for the treatment of inpatients with acute severe ulcerative colitis
Almost a fourth of renal cysts had pathologically high-grade disease, which did not have a correlation with growth rate or increase the risk with active
On Friday, President Biden announced his intent to choose former top North Carolina health official Mandy Cohen, MD, MPH, to lead the CDC. “Dr. Cohen
The use of flibanserin (Addyi) in women with breast cancer was associated with improvements in medically and treatment-induced decreased libido, according to a study presented
CHICAGO — Testosterone-replacement therapy was noninferior to placebo in the occurrence of major adverse cardiac events among men with hypogonadism and established or high risk